LOGO
LOGO

Quick Facts

Dow Jones And Cision Resolve Copyright Infringement Claim - Quick Facts

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News
rttnewslogo20mar2024

Dow Jones & Co., a News Corp. (NWS,NWSA) company, said that Cision AB (Sweden) and Cision US Inc., have paid a significant sum to settle a
claim based on Cision's unauthorized reproduction, distribution, and other
misuse of news content published by Dow Jones & Co., Inc., including full
text articles from The Wall Street Journal.

Dow Jones asserted copyright infringement claims against Cision in response to
Cision's regular reproduction and distribution of Dow Jones' copyrighted
articles to Cision's subscribers, who include public relations professionals at corporations throughout the United States.

Dow Jones said that its content was originally published mainly in the print and online editions of The Wall Street Journal, Barron's and SmartMoney magazines.

On March 8, 2012, Cision publicly disclosed that it had received a significant claim of rights infringement, without identifying Dow Jones as the claimant, Dow Jones said.

Dow Jones stated that the parties have agreed to settle its claims without litigation. The specific terms of the settlement remain confidential, the company said.

Dow Jones said as a result of the settlement, Cision is no longer redistributing Dow Jones' original content, and Cision's subscribers will be directed to Dow Jones if they seek to obtain such content.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - April 27 – May 01, 2026

May 01, 2026 15:54 ET
Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.

Latest Updates on COVID-19